Genetically engineered mice have been characterized as models for chronic forms of dry eye; these include the Aire mice (Chen et al., 2017; Yeh et al., 2009) and Langerin (CD207) deficient mice (Choi et al., 2017). This evidence concerns the gene CD207 and dry eye syndrome.